Therapeutic Changes And Check Point

The following for this client based on amphetamines dosage, the   daily dose will be raised in 10 mg increments at weekly intervals up to the point when the optimal response is achieved.

The “lessons learned” from the case study

One of the challenges in the case is to use effective drug to treat resistant anxious depression while taking into consideration excessive sleep symptoms. A comprehension of the electrophysiologic, as well as, neurochemical that correlates with the stages of sleep is necessary in defining sleep disorders. Just like evidenced in the patient, excessive daytime sleepiness is normally associated with disorders such as obstructive sleep apnea and depression.

References

Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press.

Ardani, A. R., Saghebi, S. A., Nahidi, M., & Zeynalian, F. (2016). Does abstinence resolve poor sleep quality in former methamphetamine dependents?. Sleep Science (sao Paulo, Brazil), 9, 3.

Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (November 01, 2016). Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clinical Therapeutics, 38, 11, 2340-2372.

Mokhlesi, B., & Cifu, A. S. (2017). Diagnostic Testing for Obstructive Sleep Apnea in Adults. Jama, 318, 20, 2035.